Leadership Transition at Teleflex Incorporated
Teleflex Incorporated (NYSE: TFX), a prominent global provider of medical technologies, is undergoing an important leadership change. Thomas E. Powell, the Chief Financial Officer (CFO) of Teleflex, has announced his upcoming retirement, effective April 1, 2025. This transition marks the end of an era for Powell, who has been a vital part of Teleflex for over 13 years.
Introducing John Deren: The New CFO
Following Powell's departure, John R. Deren, who is currently the Corporate Vice President and Chief Accounting Officer at Teleflex, will step into the CFO role effective April 2, 2025. This strategic decision is aimed at ensuring a seamless transition and maintaining continuity within the finance leadership team.
Recognizing Thomas Powell's Contributions
Liam Kelly, the Chairman, President, and Chief Executive Officer of Teleflex, expressed his gratitude towards Powell, highlighting his significant contributions to the company over the years. Powell has played a crucial role in enhancing the company’s operational success, notably increasing the adjusted operating margin by 800 basis points from 2012 to 2024. His efforts have been instrumental in shaping a robust financial organization, positioning Teleflex for future success.
A Consultant Role Post-Retirement
After retiring, Powell will continue to offer his expertise as a consultant until March 31, 2026. This decision facilitates a smooth transition while preserving the wealth of knowledge and experience Powell brings to the table.
John Deren's Journey within Teleflex
Deren has a rich background in finance, having been with Teleflex since 2013. During these years, he has held various key roles within the finance department, overseeing functions such as Corporate Finance, Global Supply Chain Finance, Treasury, and Tax. His extensive experience spans over 30 years, including leadership positions at well-known companies like Rohm and Haas, Exelon Generation, and Trinseo, where he honed his skills before joining Teleflex.
Teleflex’s Commitment to Healthcare Innovation
With new leadership under Deren, Teleflex remains committed to its mission of improving health quality through innovative medical technologies. The company strives to be a trusted partner in healthcare, offering a diverse range of products across several therapeutic areas including anesthesia, emergency medicine, interventional cardiology, surgical procedures, and urology.
Brands and Innovations at Teleflex
Teleflex is home to a variety of respected brands, including Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™, Rüsch™, UroLift™, and Weck™, each associated with a dedication towards high-quality healthcare solutions. The company believes that driven innovation, combined with a focus on people, can significantly influence the healthcare landscape.
Looking Forward
As Teleflex transitions into this new chapter, the leadership team is optimistic about its future. The company’s cohesive approach to finance and operations under John Deren’s guidance aims to enhance the execution of its growth strategy, ensuring the organization remains poised for success in the evolving healthcare market.
Frequently Asked Questions
What is the effective retirement date for Thomas Powell?
Thomas Powell’s retirement will take effect on April 1, 2025.
Who will succeed Thomas Powell as CFO of Teleflex?
John R. Deren will take over as the Chief Financial Officer of Teleflex effective April 2, 2025.
What are Thomas Powell's contributions to Teleflex?
Powell has significantly improved the company's adjusted operating margin and built a robust finance structure over his 13 years.
What is John Deren's background in finance?
Deren has over 30 years of financial experience, including key roles in multiple recognized companies before joining Teleflex.
What is Teleflex's mission in healthcare?
Teleflex aims to enhance the health and quality of life for people through innovative medical technologies and trusted healthcare partnerships.
